Augmedix Financial Statements From 2010 to 2024
| AUGXDelisted Stock | USD 2.35 0.00 0.00% |
Check Augmedix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Augmedix's main balance sheet or income statement drivers, such as , as well as many indicators such as . Augmedix financial statements analysis is a perfect complement when working with Augmedix Valuation or Volatility modules.
Augmedix |
Augmedix Company Current Valuation Analysis
Augmedix's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Augmedix Current Valuation | 113.21 M |
Most of Augmedix's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Augmedix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Augmedix has a Current Valuation of 113.21 M. This is 99.21% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.32% higher than that of the company.
Augmedix Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Augmedix's current stock value. Our valuation model uses many indicators to compare Augmedix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Augmedix competition to find correlations between indicators driving Augmedix's intrinsic value. More Info.Augmedix is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Augmedix's earnings, one of the primary drivers of an investment's value.About Augmedix Financial Statements
Augmedix investors use historical fundamental indicators, such as Augmedix's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Augmedix. Please read more on our technical analysis and fundamental analysis pages.
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. The company was founded in 2013 and is headquartered in San Francisco, California. Augmedix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 706 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |